Clinical Trial: Development of a Pan-Cancer Prediction Model for Neoadjuvant Treatment Efficacy and Complications Based on Clinical Multimodal Data (China)

China, Sept. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Development of a Pan-Cancer Prediction Model for Neoadjuvant Treatment Efficacy and Complications Based on Clinical Multimodal Data'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132387

Registration Time: 2026/09/14

Type: Diagnostic test

Primary Sponsor: Zhejiang Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343231

Published by HT Digital Content Services with permission from Health Daily Digest....